We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (236)
- COVID-19 (55)
- Compliance and enforcement (48)
- Vaping hub (33)
- Import and export (21)
- Medicinal cannabis hub (19)
- Safety monitoring and information (13)
- Scheduling (national classification system) (13)
- Manufacturing (11)
- Weight loss products (8)
- Legislation (7)
- Labelling and packaging (4)
- Shortages and supply disruptions (4)
- Cosmetics (3)
- Prescription opioids hub (2)
- Unique Device Identification (UDI) hub (2)
- Committees and advisory bodies (1)
- Fees and payments (1)
- Sunscreens (1)
Search
530 result(s) found, displaying 426 to 450
-
Media releasesInSkin Cosmedics Group Pty Ltd has paid penalties of $37,800 in regards to the alleged supply and advertising of the Dermapen 4
-
Media releasesMeasles vaccine testing shows the vaccine meets required standards
-
-
Media releasesPharmacies and others can advertise availability of OTC salbutamol products during the bushfire season
-
Media releasesMundipharma Pty Ltd has paid penalties of $302,400 in response to 24 infringement notices issued by the TGA
-
-
Media releasesWe will closely consider the judgment including any further improvements that could enhance the regulatory system in Australia.
-
Media releasesAcalabrutinib receives approval through the second international collaborative review initiative between the TGA, FDA and Health Canada
-
Media releasesThe TGA has joined the ICMRA and the WHO in a coordinated global approach to fighting antimicrobial resistance
-
Media releasesConsumer Healthcare Products Australia to handle all medicine advertising pre-approval applications
-
Media releasesThe Complementary Healthcare Council of Australia is no longer accepting advertising pre-approval applications
-
Media releasesThe Therapeutic Goods Administration is aware that a member of the public has purported to be a Commonwealth public official during a recent incident in Melbourne
-
Media releasesA warning to consumers about undergoing procedures using unapproved medical devices
-
Media releasesChanges are coming in November to the advertising pre-approval arrangements for some complementary medicines advertisements
-
Media releasesThe TGA has released the findings of its review into breast implants and breast tissue expanders
-
Media releasesInternational Collaborative Review Initiative gives provisional approval of lenvatinib in combination with pembrolizumab
-
Media releasesInfringement notice issued for the alleged advertising of Schedule 4 substances
-
Media releasesInfringement notice issued for the alleged advertising of a cancelled therapeutic good
-
Media releasesUpdate on amendments to the Therapeutic Goods Advertising Code (No.2) 2018 and medicines advertising pre-approval
-
Media releasesThe TGA has commenced work on a sector-wide compliance activity relating to the advertising of bioresonance devices
-
Media releasesAn individual has been fined for the alleged importation of unapproved cosmetic products after returning from an overseas trip to China
-
Media releasesInfringement notices issued for the alleged importation and advertising of unapproved performance and image enhancing products
-
Media releasesInformation on how supplements are regulated in Australia
-
Media releasesImprovements to Consumer Medicine Information
-
Media releasesImportant information about the dangers of using thermography for breast cancer detection